DK1844070T3 - Peptider med neuropeptid-2 receptor (Y2R) agonistaktivitet - Google Patents

Peptider med neuropeptid-2 receptor (Y2R) agonistaktivitet

Info

Publication number
DK1844070T3
DK1844070T3 DK06700451.5T DK06700451T DK1844070T3 DK 1844070 T3 DK1844070 T3 DK 1844070T3 DK 06700451 T DK06700451 T DK 06700451T DK 1844070 T3 DK1844070 T3 DK 1844070T3
Authority
DK
Denmark
Prior art keywords
neuropeptide
peptides
receptor
agonist activity
agonist
Prior art date
Application number
DK06700451.5T
Other languages
English (en)
Inventor
Waleed Danho
George Ehrlich
David C Fry
Wajiha Khan
Joseph Swistok
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK1844070T3 publication Critical patent/DK1844070T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57545—Neuropeptide Y
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK06700451.5T 2005-01-18 2006-01-11 Peptider med neuropeptid-2 receptor (Y2R) agonistaktivitet DK1844070T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64484005P 2005-01-18 2005-01-18
PCT/EP2006/000161 WO2006077035A1 (en) 2005-01-18 2006-01-11 Peptides with neuropeptide-2 receptor (y2r) agonist activity

Publications (1)

Publication Number Publication Date
DK1844070T3 true DK1844070T3 (da) 2011-06-14

Family

ID=36118121

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06700451.5T DK1844070T3 (da) 2005-01-18 2006-01-11 Peptider med neuropeptid-2 receptor (Y2R) agonistaktivitet

Country Status (22)

Country Link
US (1) US7410949B2 (da)
EP (1) EP1844070B1 (da)
JP (1) JP4633804B2 (da)
KR (1) KR100905380B1 (da)
CN (1) CN101107266A (da)
AR (1) AR051904A1 (da)
AT (1) ATE500268T1 (da)
AU (1) AU2006207659B2 (da)
BR (1) BRPI0606675A2 (da)
CA (1) CA2594423A1 (da)
DE (1) DE602006020407D1 (da)
DK (1) DK1844070T3 (da)
ES (1) ES2359850T3 (da)
IL (1) IL184428A0 (da)
MX (1) MX2007008614A (da)
NO (1) NO20073664L (da)
PL (1) PL1844070T3 (da)
PT (1) PT1844070E (da)
RU (1) RU2383553C2 (da)
TW (1) TWI309653B (da)
WO (1) WO2006077035A1 (da)
ZA (1) ZA200705674B (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ568772A (en) * 2005-12-07 2010-05-28 Hoffmann La Roche Truncated analogs of the peptide pYY3-36 that are neuropeptide-2 receptor-agonists
US8299023B2 (en) * 2008-09-17 2012-10-30 Hoffmann-La Roche Inc. Neuropeptide-2 receptor (Y-2R) agonists
EP2352511A2 (en) * 2008-11-05 2011-08-10 F. Hoffmann-La Roche AG Neuropeptide-2-receptor (y-2r) agonists and uses thereof
WO2011002066A1 (ja) * 2009-07-02 2011-01-06 武田薬品工業株式会社 ペプチド及びその用途
EP2477643A1 (en) * 2009-09-18 2012-07-25 Novo Nordisk A/S Long-acting y2 receptor agonists
EP2488195A2 (en) * 2009-10-13 2012-08-22 F. Hoffmann-La Roche AG Neuropeptide-2 receptor (y-2r) agonists
PT2651398T (pt) 2010-12-16 2018-03-09 Novo Nordisk As Composições sólidas compreendendo um agonista de glp-1 e um sal de ácido n-(8-(2-hidroxibenzoil)amino) caprílico
HUE062740T2 (hu) 2012-03-22 2023-12-28 Novo Nordisk As GLP-1 peptidek készítményei és elõállításuk
CA2872213A1 (en) 2012-06-13 2013-12-19 F. Hoffmann-La Roche Ag New diazaspirocycloalkane and azaspirocycloalkane
UA116547C2 (uk) 2012-09-25 2018-04-10 Ф. Хоффманн-Ля Рош Аг Біциклічні похідні
AR095079A1 (es) 2013-03-12 2015-09-16 Hoffmann La Roche Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo
SI3068421T1 (sl) 2013-11-15 2019-08-30 Novo Nordisk A/S Selektivne spojine PYY in njihova uporaba
EP3068795B1 (en) 2013-11-15 2019-03-06 Novo Nordisk A/S Hpyy(1-36) having a beta-homoarginine substitution at position 35
CN105764905B (zh) 2013-11-26 2019-06-07 豪夫迈·罗氏有限公司 新的八氢-环丁二烯并[1，2-c；3，4-c’]二吡咯-2基
CA2935612A1 (en) 2014-03-26 2015-10-01 F. Hoffmann-La Roche Ag Condensed [1,4]diazepine compounds as autotaxin (atx) and lysophosphatidic acid (lpa) production inhibitors
HUE046820T2 (hu) 2014-03-26 2020-03-30 Hoffmann La Roche Biciklusos vegyületek autotaxin (ATX) és lizofoszfatidsav (LPA) termelésgátlókként
MA41898A (fr) 2015-04-10 2018-02-13 Hoffmann La Roche Dérivés de quinazolinone bicyclique
BR112017025108A2 (pt) 2015-06-12 2018-07-31 Novo Nordisk As compostos seletivos de pyy e usos dos mesmos
CR20180058A (es) 2015-09-04 2018-02-26 Hoffmann La Roche Nuevos derivados de fenoximetilo
CA2991615A1 (en) 2015-09-24 2017-03-30 F. Hoffmann-La Roche Ag Bicyclic compounds as atx inhibitors
JP6846414B2 (ja) 2015-09-24 2021-03-24 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ Ａｔｘ阻害剤としての二環式化合物
CN107614505B (zh) 2015-09-24 2021-05-07 豪夫迈·罗氏有限公司 作为双重atx/ca抑制剂的新型二环化合物
EP3353178B1 (en) 2015-09-24 2021-07-14 F. Hoffmann-La Roche AG Bicyclic compounds as dual atx/ca inhibitors
CN110382484B (zh) 2017-03-16 2022-12-06 豪夫迈·罗氏有限公司 新的作为atx抑制剂的二环化合物
KR20190129924A (ko) 2017-03-16 2019-11-20 에프. 호프만-라 로슈 아게 이중 오토탁신(atx)/탄산 무수화효소(ca) 억제제로서 유용한 헤테로환형 화합물
EP3717508A1 (en) 2017-12-01 2020-10-07 The University of Copenhagen Peptide hormone with one or more o-glycans
BR112020014624A2 (pt) 2018-02-02 2020-12-08 Novo Nordisk A/S Composições sólidas compreendendo agonista de glp-1, sal de ácido n-(8-(2-hidroxibenzoil) amino)caprílico e lubrificante
EP3800195A1 (en) * 2019-10-03 2021-04-07 Universitat de Barcelona Peptide compounds for reducing side effects of cb1 receptor agonists

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5080891A (en) 1987-08-03 1992-01-14 Ddi Pharmaceuticals, Inc. Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols
WO1994022467A1 (en) 1993-03-29 1994-10-13 University Of Cincinnati Analogs of peptide yy and uses thereof
US6017879A (en) * 1998-04-03 2000-01-25 B.M.R.A. Corporation B.V. Template associated NPY Y2-receptor agonists
US7811989B2 (en) * 2003-01-17 2010-10-12 Ipsen Pharma S.A.S. Peptide YY analogs
WO2005053726A1 (en) * 2003-11-25 2005-06-16 Bayer Pharmaceuticals Corporation Selective neuropeptide y2 receptor agonists
EP1789440A4 (en) * 2004-02-11 2008-03-12 Amylin Pharmaceuticals Inc REASONS FOR THE FAMILY OF PANCREATIC POLYPEPTIDES AND POLYPEPTIDES CONTAINING THEM

Also Published As

Publication number Publication date
EP1844070B1 (en) 2011-03-02
ATE500268T1 (de) 2011-03-15
PL1844070T3 (pl) 2011-07-29
US7410949B2 (en) 2008-08-12
NO20073664L (no) 2007-09-28
RU2383553C2 (ru) 2010-03-10
DE602006020407D1 (de) 2011-04-14
BRPI0606675A2 (pt) 2009-07-07
RU2007131504A (ru) 2009-02-27
KR100905380B1 (ko) 2009-06-30
AU2006207659B2 (en) 2009-10-29
MX2007008614A (es) 2007-09-11
EP1844070A1 (en) 2007-10-17
PT1844070E (pt) 2011-05-04
ZA200705674B (en) 2009-08-26
WO2006077035A1 (en) 2006-07-27
KR20070095422A (ko) 2007-09-28
AR051904A1 (es) 2007-02-14
JP2008527017A (ja) 2008-07-24
WO2006077035A9 (en) 2006-10-26
TW200637874A (en) 2006-11-01
IL184428A0 (en) 2007-10-31
JP4633804B2 (ja) 2011-02-16
ES2359850T3 (es) 2011-05-27
CN101107266A (zh) 2008-01-16
TWI309653B (en) 2009-05-11
US20060160742A1 (en) 2006-07-20
CA2594423A1 (en) 2006-07-27
AU2006207659A1 (en) 2006-07-27

Similar Documents

Publication Publication Date Title
DK1844070T3 (da) Peptider med neuropeptid-2 receptor (Y2R) agonistaktivitet
ATE549350T1 (de) Neuropeptid-2-rezeptor-agonisten
DK1711465T3 (da) Hydroisoindolin-tachykinikreceptorantagonister
DK2653465T3 (da) Opioid-receptormodulatorer
ATE452886T1 (de) Chemokinrezeptorantagonisten
DE602005018568D1 (de) Bildschirmhalterungsvorrichtung
DE602006007563D1 (de) Agonisten
DK1973886T3 (da) Prokineticin-1-receptor-antagonister
DK1781657T3 (da) Medikamenter med hm74a-receptor aktivitet
DE502005007052D1 (de) Sitzbefestigungsvorrichtung
DK1776133T3 (da) Peptid-vasopressin-receptor-agonister
DE602005021211D1 (de) Befestigungsvorrichtung
ES1064680Y (es) Estructura portante de receptor
DE602005013240D1 (de) Flugzeugsitz
FI7468U1 (fi) Pehmuste
DE602004026543D1 (de) Auslegeraufhängung
NO20051780A (no) Sitteunderlag
FR2880112B1 (fr) Pese-personne
FR2871811B1 (fr) Endofucanase recombinante
DK1735330T3 (da) Progesteronreceptormodulatorer
ES1057549Y (es) Estructura de hamaca
SE0400275D0 (sv) New polypeptide
ATE551034T1 (de) Urinaufnehmer
FIU20040056U0 (fi) Kannettava selkätuki
FI6626U1 (fi) Tuki